Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Blocking androgens at birth reduces sexual motivation in male rats.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Men use cosmetic surgery to feel and look better, often influenced by traditional masculinity ideals.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Laser pubic hair removal boosts self-esteem, body image, and sexual functions in women.

Married Egyptian women with PCOS have lower sexual desire compared to those without PCOS.

Anabolic steroid abuse can cause sexual, fertility, and health problems.

PCOS increases sexual pain distress in infertile women.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Women with PCOS often have sexual problems, and treating these issues early can improve satisfaction and reduce healthcare costs.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.